Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Abbott Targets Amneal in Latest Fight Over Generic Niaspan
Sept. 5, 2012
Abbott Laboratories’ AbbVie hit Amneal Pharmaceuticals with a patent suit in Delaware Federal Court, arguing that Amneal has infringed a patent covering its cholesterol medication, Niaspan.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing